1. Home
  2. RFL vs ACCL Comparison

RFL vs ACCL Comparison

Compare RFL & ACCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rafael Holdings Inc. Class B

RFL

Rafael Holdings Inc. Class B

HOLD

Current Price

$1.27

Market Cap

54.4M

Sector

Finance

ML Signal

HOLD

ACCL

Acco Group Holdings Limited Ordinary Shares

N/A

Current Price

$3.25

Market Cap

57.8M

ML Signal

N/A

Company Overview

Basic Information
Metric
RFL
ACCL
Founded
2017
2009
Country
United States
Hong Kong
Employees
N/A
N/A
Industry
Real Estate
Professional Services
Sector
Finance
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
54.4M
57.8M
IPO Year
N/A
2025

Fundamental Metrics

Financial Performance
Metric
RFL
ACCL
Price
$1.27
$3.25
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
203.9K
82.0K
Earning Date
12-11-2025
02-20-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
2.91
EPS
N/A
0.08
Revenue
$1,029,000.00
$4,888,824.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$35.11
Revenue Growth
47.63
11.91
52 Week Low
$1.12
$2.10
52 Week High
$3.19
$5.00

Technical Indicators

Market Signals
Indicator
RFL
ACCL
Relative Strength Index (RSI) 53.74 N/A
Support Level $1.12 N/A
Resistance Level $1.28 N/A
Average True Range (ATR) 0.09 0.00
MACD 0.01 0.00
Stochastic Oscillator 73.91 0.00

Price Performance

Historical Comparison
RFL
ACCL

About RFL Rafael Holdings Inc. Class B

Rafael Holdings Inc is a holding company with interests in clinical and early-stage pharmaceutical companies. Its primary focus is to expand its investment portfolio through opportunistic investments including therapeutics, which address high unmet medical needs. Through the companies it has invested in, the company is focused on; developing Trappsol Cyclo its clinical program, developing instruments to advance minimally invasive surgeries, preclinical cancer metabolism research operations, and developing pharmaceutical-grade technology Unlokt for third-party cannabis manufacturers. It also holds and manages commercial real estate assets in Jerusalem, Israel. The company's reportable segments are; Infusion Technology, which derives maximum revenue, Healthcare, and Real Estate.

About ACCL Acco Group Holdings Limited Ordinary Shares

Acco Group Holdings Ltd is a holding company. Through its Operating Subsidiaries, it is a multi-disciplinary, IT-driven corporate service provider with a presence in Hong Kong and Singapore. Under the Accolade brand, it specializes in offering corporate secretarial services and accounting services in Hong Kong, as well as intellectual properties (IP) registration services in Singapore. Leveraging developed IT solutions, It provides comprehensive, reliable and professional support to its clients, enabling them to focus on their core business activities while it manages and handles their corporate compliance needs. Its clientele ranges from individual clients, small and medium-sized enterprises to multinational corporations, reflecting its ability to cater to diverse business needs.

Share on Social Networks: